Paper35328366
The Efficacy of Fibrinogen Concentrates in Relation to Cryoprecipitate in Restoring Clot Integrity and Stability against Lysis.
Whyte CS and 4 others. Int J Mol Sci, 2022. Cited by 17 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Efficacy of Fibrinogen Concentrates in Relation to Cryoprecipitate in Restoring Clot Integrity and Stability against Lysis. Papers, record 35328366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35328366
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Efficacy of Fibrinogen Concentrates in Relation to Cryoprecipitate in Restoring Clot Integrity and Stability against Lysis.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Coagulation Disorders | Major topic |
| Hemostatics | Major topic |
| Thrombosis | Major topic |
| Factor XIII | |
| Fibrin | |
| Fibrinogen | |
| Humans | |
| Thrombelastography |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PG/15/82/31721 | British Heart Foundation | United Kingdom | PubMed | |
| PG/20/17/35050 | British Heart Foundation | United Kingdom | PubMed | |
| N/A | Friends of Anchor | PubMed | ||
| G17.03 | Tenovus Scotland Grampian | PubMed |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26,218,701 | Mechanisms of early trauma-induced coagulopathy: The clot thickens or not? | J Trauma Acute Care Surg | 2015 | https://conductscience.org/library/papers/26218701 | PubMed |
| 2 | 106,487 | Fibrin crosslinks and lysis rates. | Thromb Res | 1979 | https://conductscience.org/library/papers/106487 | PubMed |
| 3 | 7,199,538 | Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. | J Clin Invest | 1982 | https://conductscience.org/library/papers/7199538 | PubMed |
| 4 | 18,272,815 | Dynamic imaging of fibrin network formation correlated with other measures of polymerization. | Blood | 2008 | https://conductscience.org/library/papers/18272815 | PubMed |
| 5 | 31,735,326 | Aggregates Dramatically Alter Fibrin Ultrastructure. | Biophys J | 2020 | https://conductscience.org/library/papers/31735326 | PubMed |
| 6 | 24,261,582 | The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis. | J Thromb Haemost | 2014 | https://conductscience.org/library/papers/24261582 | PubMed |
| 7 | 15,968,395 | Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. | Thromb Haemost | 2005 | https://conductscience.org/library/papers/15968395 | PubMed |
| 8 | 30,917,843 | The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. | Crit Care | 2019 | https://conductscience.org/library/papers/30917843 | PubMed |
| 9 | 24,172,764 | The role of fibrinogen in trauma-induced coagulopathy. | Hamostaseologie | 2014 | https://conductscience.org/library/papers/24172764 | PubMed |
| 10 | 22,153,684 | Fibrinogen replacement therapy: a critical review of the literature. | Blood Transfus | 2012 | https://conductscience.org/library/papers/22153684 | PubMed |
| 11 | 20,586,921 | Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis. | J Thromb Haemost | 2010 | https://conductscience.org/library/papers/20586921 | PubMed |
| 12 | 12,053,001 | Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. | Stroke | 2002 | https://conductscience.org/library/papers/12053001 | PubMed |
| 13 | 15,967,976 | The elasticity of an individual fibrin fiber in a clot. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/15967976 | PubMed |
| 14 | 34,247,096 | Differences in the biochemical composition of three plasma derived human fibrinogen concentrates. | Thromb Res | 2021 | https://conductscience.org/library/papers/34247096 | PubMed |
| 15 | 27,472,424 | Perioperative Coagulation Management in a Patient with Congenital Afibrinogenemia during Revision Total Hip Arthroplasty. | Semin Thromb Hemost | 2016 | https://conductscience.org/library/papers/27472424 | PubMed |
| 16 | 28,304,129 | Development of Shiny app tools to simplify and standardize the analysis of hemostasis assay data: communication from the SSC of the ISTH. | J Thromb Haemost | 2017 | https://conductscience.org/library/papers/28304129 | PubMed |
| 17 | 12,941,043 | Thrombus lysis by uPA, scuPA and tPA is regulated by plasma TAFI. | J Thromb Haemost | 2003 | https://conductscience.org/library/papers/12941043 | PubMed |
| 18 | 29,914,530 | Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomised, double blind, placebo-controlled pilot trial. | Crit Care | 2018 | https://conductscience.org/library/papers/29914530 | PubMed |
| 19 | 27,956,676 | Fibrinogen in the initial resuscitation of severe trauma (FiiRST): a randomized feasibility trial. | Br J Anaesth | 2016 | https://conductscience.org/library/papers/27956676 | PubMed |
| 20 | 33,671,748 | Fibrinogen Replacement Therapy for Traumatic Coagulopathy: Does the Fibrinogen Source Matter? | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33671748 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,793,136 | Coagulation Assessment and Fibrinogen Thresholds in Therapeutic Plasma Exchange-A Narrative Review. | Biomolecules | 2026 | https://conductscience.org/library/papers/42793136 | PubMed |
| 42,786,412 | Clinical and physiologic factors associated with early hypofibrinogenemia in trauma. | CJEM | 2026 | https://conductscience.org/library/papers/42786412 | PubMed |
| 42,196,037 | Fibrin Gel as a Versatile Biomaterial Platform in the Biomedical Landscape: Chemical, Physical, and Biological Insights. | Gels | 2026 | https://conductscience.org/library/papers/42196037 | PubMed |
| 41,932,157 | Blood product supplementation modulates clotting kinetics, mechanics, and fibrin architecture in an in vitro model of trauma-induced coagulopathy. | Thromb Res | 2026 | https://conductscience.org/library/papers/41932157 | PubMed |
| 41,695,328 | Pulsed ultrasound-stimulated microbubbles alter the tumor blood supply to enhance the efficacy of high-intensity focused ultrasound ablation of vascular tumors. | Front Oncol | 2026 | https://conductscience.org/library/papers/41695328 | PubMed |
| 38,873,197 | Are all fibrinogen concentrates the same? The effects of two fibrinogen therapies in an afibrinogenemic patient and in a fibrinogen deficient plasma model. A clinical and laboratory case report. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/38873197 | PubMed |
| 38,068,548 | Comparison of Fibrinogen Concentrate and Cryoprecipitate on Major Thromboembolic Events after Living Donor Liver Transplantation. | J Clin Med | 2023 | https://conductscience.org/library/papers/38068548 | PubMed |
| 37,432,214 | Significance of 1,25-Dihydroxyvitamin D3 on Overall Mortality in Peritoneal Dialysis Patients with COVID-19. | Nutrients | 2023 | https://conductscience.org/library/papers/37432214 | PubMed |
| 36,531,720 | "Going with the flow" in modeling fibrinolysis. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/36531720 | PubMed |
| 36,163,263 | Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trial. | Crit Care | 2022 | https://conductscience.org/library/papers/36163263 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| F13A1 | 2,162 | PubTator's text mining | https://conductscience.org/library/genes/2162 | NCBI Gene |
| F2 | 2,147 | PubTator's text mining | https://conductscience.org/library/genes/2147 | NCBI Gene |
| FGB | 2,244 | PubTator's text mining | https://conductscience.org/library/genes/2244 | NCBI Gene |
| PLAT | 5,327 | PubTator's text mining | https://conductscience.org/library/genes/5327 | NCBI Gene |
| PLG | 5,340 | PubTator's text mining | https://conductscience.org/library/genes/5340 | NCBI Gene |
| SERPINE1 | 5,054 | PubTator's text mining | https://conductscience.org/library/genes/5054 | NCBI Gene |
| SERPINF2 | 5,345 | PubTator's text mining | https://conductscience.org/library/genes/5345 | NCBI Gene |
| VWF | 7,450 | PubTator's text mining | https://conductscience.org/library/genes/7450 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35328366
GET https://conductscience.org/api/papers/v1/35328366/references?page=2